Cadila Healthcare submits press release

16 May 2020 Evaluate

Cadila Healthcare has informed that the Company enclosed a Press Release dated May 16, 2020 titled ‘Zydus Cadila receives tentative approval from USFDA for Droxidopa Capsules, 100 mg, 200 mg, and 300 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.20 -6.40 (-0.71%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×